Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

FDA Panel Recommends Pulling Preterm Birth Drug From the Market

The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.

Christina Jewett
Author: Christina Jewett

Written by

Christina Jewett

in

Drugs (Pharmaceuticals), Food and Drug Administration, Pregnancy and Childbirth, Premature Babies, Regulation and Deregulation of Industry
←Broadway Theater To Be Renamed In Honor Of Lena Horne
Arnold Schwarzenegger And Sylvester Stallone Carve Pumpkins Together For Halloween→

More posts

  • Pure Joy: Photographer Laylah Amatullah Barrayn Captures Her First ESSENCE Festival Of Culture

  • Angry crowd confronts Republican Rep. Mike Flood at Nebraska town hall

  • Rhea Seehorn celebrates her ‘Pluribus’ Emmy nomination as she waits to hear about Carol and the atom bomb

  • Emmy Nominations Analysis: ‘The Pitt’ And ‘Hacks’ Dominance Proves It Helps To Be On A Show Voters Actually Watch

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube